The new oncology department has a dedicated chemotherapy room, access to a variety of chemotherapy drugs and a fully equipped operating theatre – offering soft tissue and orthopaedic surgery services for surgical oncology cases.
The department also has access to high frequency ocular ultrasound, magnetic resonance (MRI), and computed tomography (CT) scan equipment.
The service will be led by residency-trained clinician in Small Animal Oncology, Nina Vigevani DVM MRCVS.
She graduated in 2019 from the University of Milan, completed a rotating internship and worked in general practice in Milan, before moving to the UK to start on an oncology internship at a referral practice in the South of England.
Prior to moving to Chestergates, she completed her Residency in Small Animal Oncology at the University of Liverpool.
To refer a case: https://chestergates.org.uk/referral-services.
45% of British pet owners believe their four legged friends share their human emotions and can sense when they are upset or unwell, according to a new survey announced by Bayer Animal Health.
The 'Pets are Human Too' study of 3,000 British dog and cat owners was commissioned by the company to celebrate Drontal's www.mypetsuperstar.com competition.
According to the study:
TV vet and My Pet Superstar Judge Emma Milne, said: "The joy and companionship our pets bring to our lives is unquestionable and it is no wonder that many consider them to be 'man's best friend'. Britain is a nation of proud pet owners and now, with the launch of My Pet Superstar, we all have a chance to show them off!"
Alstoe, maker of a range of veterinary products including Easeflex, Vetergesic, Dolagis and Nelio, has announced that it has changed its name to Sogeval UK Ltd following its acquisition by Sogeval, the French veterinary drug company, earlier this year.
The company says customers will not notice any change to their dealings with the company, because Sogeval UK Ltd will trade from the same premises near York and with the same staff members.
Niall McFerran, Sogeval Country Manager, UK and ROI said: "The change of name to Sogeval UK Ltd aligns the business to one of the world's fastest growing Animal Health companies. Through Sogeval's research and development programmes, we look forward to exciting improvements in the future."
For any questions relating to the change, practices are invited to contact Niall McFerran on 01347 878606.
Sioned Timothy, Ruminant Technical Manager at Boehringer said: "The financial and production impact of liver fluke should not be underestimated. Recent abattoir research in Ireland, published this year, has shown that a fattening steer with fluke infection will put on 36kg less live weight gain over its lifetime versus a healthy steer, costing the producer around £63, per animal.
"Additionally, analysis of data from cattle at a Scottish abattoir showed that animals with 1 to 10 liver fluke present in their liver took an average 31 days longer to reach slaughter weight, while animals with more than 10 liver fluke present took an additional 77 days longer to reach slaughter weight versus animals without any liver fluke infection2.
"Liver fluke infections can also lead to hormonal and metabolic imbalances, affecting reproduction in female animals and extending breeding targets3. Affected animals may also be more susceptible to secondary bacterial infections, such as Salmonella and Clostridial infections3."
Boehringer says that with cattle being brought in for winter housing, now is an ideal opportunity to remove productivity-limiting parasites that were acquired during the grazing season. The main targets for parasite control at this time of year are gutworms, lungworm and liver fluke, however the specific risk will vary from farm to farm.
The company adds that the choice of treatment for liver fluke at housing is complicated by emerging resistance to triclabendazole. This is the only flukicide that treats the early immature stage of liver fluke, responsible for acute disease in sheep but not of clinical relevance in cattle.
Sioned said: "Prescribing an alternative flukicide for cattle at housing will reduce selection for resistance and, by targeting the later stages of the parasite, control the impact of liver fluke on productivity.
"Flukicides containing clorsulon (contained in Ivomec Super) will remove the adult stages of fluke in cattle, while those containing closantel, or nitroxynil (the active ingredient of Trodax), are effective against both late immature and adult stages.
"To ensure that cattle have no residual fluke burden, they may need to be re-treated at an appropriate interval after the initial housing dose. Diagnostic testing can be used to determine whether a second treatment is necessary. This approach will ensure that cattle are turned back out onto pasture fluke free."
References
Speakers include Dr Ian Stroud, founder and veterinary director of Pet People, an independent small animal practice in Richmond, South West London, Jack Peploe, a veterinary IT expert and Certified Ethical Hacker, and Ciaran Milford, ezyVet’s EMEA sales manager, who has worked with every type of veterinary practice, from aspiring independents right through to established universities and corporate groups.
Lance Rice, creative director at ezyVet, who will moderate the webinar, said: “This webinar is for anyone who feels as though they’ve gone as far as they can in a senior vet or clinic director role, and thinks it might be time to follow their dream of opening their own practice.
“Our speakers are all vastly experienced and ideally positioned to explain what makes a successful launch, as well as the key mistakes and common traps that new owners fall into.
"Ian has a unique understanding of the challenges and opportunities involved with starting a veterinary practice.
"Jack is an expert in helping practices leverage technology to save time, whilst delivering exceptional patient care and bolstering their security posture.
"Ciaran is passionate about helping practices find the right solutions for their needs and business goals."
To register, visit: https://www.ezyvet.com/webinar/starting-a-vet-practice-uk
The research was carried out by scientists from Wisdom Panel, a pet DNA testing company that is part of Mars Petcare’s Science & Diagnostics division.
The discovery was made by analysing clinical data from Banfield Pet Hospital paired with DNA data from Wisdom Panel.
The researcher say estimates suggest canine atopic dermatitis affects up to 10-30% of dogs, and that these findings could lead to more targeted solutions in the future.
In addition, identification of the SLAMF1 variant presents the opportunity for breeders to breed toward dogs with a lower risk of atopic dermatitis.
Jimmy Barr, DVM, DACVECC, Chief Medical Officer for Mars Petcare’s Science & Diagnostics division said: “This finding could have a real impact on dog health
"While atopy has long been suspected to have a genetic component, this is the first time the SLAMF1 gene has been convincingly linked to this debilitating skin condition.
"This knowledge will help identify dogs at risk and could lead to new therapies and more informed dog breeding practices.”
Wisdom Panel has developed a DNA test that will be offered in partnership with Canine Genetic Testing at the Department of Veterinary Medicine, University of Cambridge so breeders can make informed decisions to reduce the frequency of atopic dermatitis while maintaining genetic diversity.
Reference
https://www.cagt.co.uk
Photo: https://depositphotos.com
Norbrook Laboratories has launched NoroQuin, a nutritional glucosamine-based supplement which the company claims will help maintain healthy cartilage and joint fluids in cats, dogs and horses.
The NoroQuin range has six active ingredients including glucosamine, chondroitin sulphate, manganese sulphate, zinc sulphate, absorbic acid and N-Acetyl-D-Glucosamine which combine to maintain glycosaminoglycans (GAGs) levels in joints and, according to Norbrook, ease and reduce the onset of joint damage and cartilage degeneration.
Michelle Jones, Norbrook Brand Manager, said: "Our new NoroQuin range is an exciting new development to our joint-management range.
"NoroQuin offers more ingredients than the competition with 6 active ingredients working together to help improve mobility. The main ingredient, glucosamine stimulates natural repair and prevents cartilage degeneration and thinning while it is widely considered that glucosamine and chondroitin sulphate have anti-inflammatory properties, making Noroquin ideal for assisting with pain management. The addition of manganese sulphate helps stimulate natural cartilage repair."
NoroQuin is available in a range of meat flavoured tablet sizes that have been formulated to treat all dogs from growing puppies to the largest dogs. For cats, the range is available in a tablet form or as a powder which can be added to a cat's food.
NoroQuin for dogs and cats is available to order from wholesalers now.
Ceva Animal Health has highlighted a new study which revealed that the use of the opioid buprenorphine, the active ingredient in Vetergesic, before equine elective general anaesthesia and surgery resulted in better post-operative analgesia than butorphanol, without causing further physiological disruption than is normally expected of general anaesthesia in horses.
The prospective, randomised and blinded multicentre study, conducted by Dr Polly Taylor VetMB MA PhD DVA DipECVAA MRCA MRCVS, an RCVS Specialist in Veterinary Anaesthesia, compared the degree of post-operative pain and physiological variables in horses following premedication with either buprenorphine or butorphanol in a general clinical setting. The study included 89 healthy adult horses from six UK equine veterinary clinics admitted for routine elective surgical procedures.
Ceva says that butorphanol is often used in equine procedures due to familiarity and its value for enhancing alpha2-induced sedation, but that it is probably the least effective opioid as an analgesic. There is also a common perception that butorphanol has less impact on locomotor stimulation and depression of intestinal motility than other opioids. This is likely to have contributed to the almost exclusive use of NSAIDs to manage pain in the post-operative period.
To view the full study, visit http://onlinelibrary.wiley.com/doi/10.1111/evj.12442/abstract. For details on Ceva's analgesic product range, email analgesics-group@ceva.com or call 01494 781510.
The VetCT teleconsulting service, which can be accessed via the web and an app-based platform, provides advice from a specialist team.
Typically advice is provided as a written report within 24 hours, with options for text chat or telephone conversations when vets may want to discuss the case with a specialist.
The service can be accessed on a pay-per-case or subscription basis.
Until now, follow-up advice had been capped at two weeks.
Internal medicine specialist and Head of Teleconsulting at VetCT, Kate Murphy, said: “We are delighted to be extending our support for cases that require ongoing management, such as endocrine disorders or complex wound management.
"Our clients have fed back how valuable it will be to partner with us longer term for these patients, to provide guidance and reassurance that care is being optimised and help to keep owners engaged and happy.”
welcome.vet-ct.com/sales
Inocul8 and the Global Alliance for Livestock Veterinary Medicines (GALVmed), have launched vetvac.org a free new online database of information about livestock and poultry vaccines.
Currently the Vetvac database contains information on nearly 2,000 livestock vaccine products produced by more than 95 manufacturers. This included cattle, sheep, goat, pig and poultry vaccines available in the UK, Australia, Africa, India, South America and the United States. It is being expanded and updated on a continuous basis, and aims to cover all markets, providing the most complete compendium of licensed livestock vaccine products available worldwide.
The database developers say that they hope Vetvac.org will be especially useful to vaccine manufacturers and developers, and animal health professionals and livestock keepers.
Josef Geoola, Vetvac's co-founder, said: "Although there are a number of on-line databases and websites that focus on livestock vaccines, none provide the global coverage that Vetvac.org aims to achieve - our product will be unique."
The new.graduatevet programme (or 'Dot' programme) offers hands-on surgical training and seminars from Advanced Practitioners at Pets'n'Vets' Roundhouse Veterinary Hospital in Glasgow, together with a dedicated website for all new and recent graduates: www.new.graduatevet.co.uk.
Pets'n'Vets says the programme has now been further enhanced by the addition of new CPD elements and the provision of additional monthly benchmarking and seminars.
Oliver Jackson, a partner at Pets‘n’Vets, said: "This is the best well-rounded, supported and unique new graduate training programme available in Scotland. Support is delivered through an integrated mentor system, peer-to-peer learning opportunities and regular case reviews, with the programme designed to integrate with, and augment, the PDP requirements, all in a clinically-driven setting free from tie-ins or financial targets."
The Dot programme sees new graduates undertake advanced training and extra practice on surgery, consultations and general practice to accelerate their skills and confidence as well as a digest of bespoke seminars aimed specifically at life in practice and optimising clinical outcomes and confidence.
The programme also includes regular periods of shadowing certificate-holding vets in a diverse range of areas, including ECC, orthopaedics, cardiology and advanced medical work-ups.
Oliver said: "We are proud to develop the programme which we believe will provide a platform for new graduates to apply the skills they’ve learned at university throughout the previous five years, and allow them to excel in their careers.
"This programme will form the first step in an ongoing personal development process and a bright future in our vet practices when they have completed their new graduate training."
Ruby Shorrock is a full-time veterinary surgeon at Pets'n'Vets who is now most of the way through last year’s inaugural Dot programme. She said: "I would heartily recommend the Dot programme to new veterinary graduates.
"The training programme enabled me to become an independent vet with all the support I need and it’s fantastic to be in a locally-owned small veterinary practice where graduates like myself get individual attention in an accredited hospital with the capacity to nurture our skills and personal development and where the gold standard I learned at university is in use every day."
New grads can apply for a place on the Dot programme by logging onto www.new.graduatevet.co.uk and emailing hr@petsnvets.org
BraveBites contains protein, fish oil (rich in omega-3) and prebiotics.
The snack, which was developed with a veterinary nutritionist, has a soft texture and high palatability.
Camille, who worked for a year at Fitzpatrick Referrals, said: “In dogs undergoing cancer treatment, decreased appetite and weight loss are common.
"They negatively affect both prognosis and quality of life.
“Owners were constantly asking what they could still give their dog when food refusal started.”
Camille says that in a field test across 40 veterinary clinics in Belgium and the Netherlands, over 95% of oncology patients accepted the snack well, with a reported improvement in appetite and quality of life
BraveBites is available direct to vets, with educational material, client brochures, and quality-of-life monitoring tools.
http://www.bravebitespetfood.com
Molar Ltd is launching a cross infection control product called VetroxxTM at this years' BSAVA Congress
VetroxxTM is a range of 100% natural disinfectant products approved by the Department of Health (HPA) for use as a hospital disinfectant and has been approved by the British Government's MAFF (now DEFRA) to control against outbreaks of significant agricultural diseases (e.g. Foot and Mouth Disease, Tuberculosis, Newcastle's Disease found in chickens & Swine Fever).
The range includes a convenient disinfectant hand gel, surface wipes and a multi-surface spray. According to Molar, VetroxxTM has been scientifically tested, proven to reduce microorganism numbers by up to 99.9998%, and kills most problem bugs, including: MRSA, Bird 'flu (H5N1), SARS, HIV, C diff and many others.
The range contains Citroxx®, a naturally-derived disinfectant made from orange pith. Molar says the product is both safe and highly biodegradable, and very kind on skin and surgery surfaces (such as examination tables, flooring and bench tops). The company adds that since Citroxx contains several antimicrobial elements, it is unlikely that resistance will develop.
During Congress, Molar will be challenging vets hand-washing skills using a special UVA (long wave UV) light box to highlight failures.
There are three full equine streams running for the duration of the two days, programmed by the Royal Veterinary College and the British Veterinary Association in partnership with the British Equine Veterinary Association. Organisers say the programme has been designed to ensure it caters for both mixed and equine only veterinary surgeons.
The lecture streams are complemented by the show’s ‘Meet the Professor’ equine sessions, where a number of the speakers are able to have more intimate discussions with a smaller group of delegates.
Topics covered in the 36 sessions include:
For more information on the BVA/BEVA Equine Theatre, RVC Equine Theatre 1 and RVC Equine Theatre 2 programmes at the London Vet Show or to register for the event visit londonvetshow.co.uk.
The Privy Council has dismissed the appeal of a Lincolnshire veterinary surgeon against the RCVS Disciplinary Committee's decision to strike him off the Register in January 2011 for serious professional misconduct.
At a two-week Disciplinary Committee hearing in January, Joseph Lennox Holmes of Waltham Veterinary Clinic, Grimsby, was found to have advised on and undertaken surgical procedures without sufficient clinical grounds or consideration of alternative treatment options; failed to obtain the informed consent of his clients; undertaken procedures outside his area of competence; failed to refer or discuss the option of referral to a specialist; and, failed to provide his patients with adequate pain relief. These findings related to two separate complaints and a total of 31 charges, of which 28 were found to amount to serious professional misconduct.
The Appeal was heard by Baroness Hale, Lord Wilson and Lord Kerr on 1 November 2011, and their judgment was delivered on Tuesday by Lord Wilson.
There were two principal parts to Mr Holmes's appeal: firstly, that RCVS procedures for investigating and determining complaints were biased against him and infringed his human right to a fair hearing by an independent and impartial tribunal; and, secondly, a number of complaints about the DC's findings and conclusions.
According to the RCVS, their Lordships recognised that the College's regulatory framework was constrained by the existing Veterinary Surgeons Act and "support[ed] statutory reform so as to enable members of the disciplinary committees to be chosen from outside the council"; but, they were satisfied that the College had made "strenuous attempts" to ensure its disciplinary procedures were fair and in accordance with human rights legislation.
They also remarked that the College had made "elaborate efforts" to separate the membership and work of the three RCVS Committees that produce guidance, investigate complaints and adjudicate on complaints, respectively. Their Lordships considered that "a fair-minded and informed observer [having considered all the facts] would not conclude there was a real possibility that the DC was biased against Mr Holmes".
Their Lordships also dismissed all of the 'deficiencies' that Mr Holmes had sought to identify in the DC's findings and conclusions. They generally preferred the College's evidence, witness accounts and expert witness testimony, and felt the DC had correctly considered the multiple charges before it.
They also found that the expertise of the DC in assessing the standards of the profession was "entitled to substantial respect" and agreed that the only sanction appropriate to Mr Holmes' "catalogue of egregious misconduct" was the removal of his name from the Register.
"[This sanction] was the only disposal which could properly reflect the primary need to serve both the interests of animal welfare and the reputation of the veterinary profession," they concluded.
Their Lordships' decision is now subject to approval by the Crown, following which, Mr Holmes would be removed from the Register and no longer entitled to practise as a veterinary surgeon.
Wiley has announced the joint online publication of a special issue of 22 ophthalmology papers from Equine Veterinary Journal, Equine Veterinary Education and Veterinary Ophthalmology.
Clinical equine ophthalmology: The current state of the art brings together papers on some of the most significant advances in equine clinical ophthalmology into a single issue to make them more readily available to a wider audience. The issue contains information of direct relevance to all sectors of the veterinary profession from general practitioners and specialists to researchers, surgeons and students, covering common diseases, surgical procedures and outcomes.
The new publication was devised and compiled by a panel of guest editors comprising Mary Lassaline, member of the Veterinary Ophthalmology Editorial board and Veterinary Ophthalmologist in the Department of Surgical and Radiological Sciences at UC-Davis School of Veterinary Medicine, California, David A. Wilkie, Editor of Veterinary Ophthalmology and Professor at Veterinary Clinical Sciences Comparative Ophthalmology Ohio State University, Tim Mair, Editor of Equine Veterinary Education based at Bell Equine Veterinary Clinic, Kent and Celia M Marr, Editor of Equine Veterinary Journal, based at Rossdales, Newmarket.Mary Lassaline said: "The goal was to provide broad access to the most current information applicable to every stratum of the equine veterinary profession. Subsequently, a salient feature is that many of the papers included are collaborations between veterinary ophthalmologists with a special interest in horses, equine practitioners with a special interest in ophthalmology, private practitioners and those in academia, and academicians from different institutions."
Subjects covered include seven papers on new approaches to the diagnosis and treatment of ulcerative and non-ulcerative keratitis in the horse. There are three articles on novel approaches to corneal surgery and a further three on corneal neoplasia. Six papers provide valuable data regarding long-term outcomes following surgical intervention for Equine Recurrent Uveitis (ERU), glaucoma, and cataracts. Finally, three articles present new information regarding retinal and orbital disease.
Professor Celia Marr, Editor of the Equine Veterinary Journal said: "The key purpose of the EVJ is to disseminate information to help the enhancement of specialist knowledge at every level of the veterinary profession. By collating the most important and up-to-date ophthalmology research into one easy resource the new special issue does exactly that."The ophthalmology special issue is available free online at: http://bit.ly/1bi0RG0
Ceva Animal Health has launched Hepaticare, a new liver support supplement for cats and dogs.
The company says Hepaticare contains the same high quality ingredients as Hepatosyl, but is now enhanced with micro-encapsulated SAMe to enhance product stability and patient acceptance.
Hepaticare contains the antioxidants of S-adenosylmethionine (SAMe), vitamin E and silybin to help maintain liver function, and vitamin K to support the normal blood clotting process. Ceva says these ingredients help neutralise damaging free radicals produced by the liver during times of stress, while the SAMe has been micro-encapsulated to enhance stability, reduce any bitter aftertaste and increase patient acceptance.
Hepaticare capsules can be given whole or opened and sprinkled onto, or mixed with, food.
Rob McLintock, companion animal business unit manager at Ceva Animal Health, said: “Following a change in supplier we have taken the opportunity to launch a new liver support supplement, ensuring that the new and improved product, Hepaticare, is as effective and as easy to administer as possible.”
Hepaticare pack sizes and pricing will remain the same as for Ceva’s Hepatosyl. Until the end of September, Hepaticare will be available on a buy one get one free offer.
For further information, contact your local Ceva territory manager or phone 01494 781510.
The PAC offers pain scale apps for dogs, cats and rabbits, a library of downloadable resources and multiple webinars released via the Animalcare Learning Alliance.
Animalcare Product Manager Kai Crawshaw said: “The PAC serves as a one-stop-shop for a wide range of resources, available in digital form and printed form if required. Whether you’re looking to offer clients educational materials on a particular clinical topic; refresh your own knowledge or take some online CPD via one of our webinars. The PAC will prove a useful and easily accessible tool for veterinary teams.
“In light of the current changes to the industry, having a fully-functional digital platform like this to provide to our customers is now more important than ever. We hope that The PAC can be enjoyed anytime, anywhere; no matter what your current circumstance is.
He added: “We would also like to extend our support and thanks to the many veterinary teams right across the UK, which are working so hard to deliver much-needed services in the challenging conditions posed by the COVID-19 pandemic.”
The PAC can be accessed here www.the-pac.co.uk.
The authors say the research marks a significant step forward in understanding how veterinary surgeons and owners can more effectively manage and prevent outbreaks of the disease.
For the study, researchers from the RVC, the University of Cambridge, the Swedish University of Agricultural Sciences and Redwings Horse Sanctuary, analysed more than 500 S. equi samples from across the UK between 2016 and 2022.
In particular, they wanted to better understand the relative contribution of short-term (immediately post infection) versus long-term carriers (carriers that were infected months or years prior).
The samples were collected from clinical cases sent to diagnostic laboratories by veterinary surgeons seeking confirmation of infection.
Surplus samples were submitted to the Surveillance of Equine Strangles network and then cultured in the RVC’s research laboratory and their DNA extracted and sequenced to reveal each bacterium’s complete genetic code.
Adopting an approach that combined whole genome sequencing and epidemiological data, the researchers were able to trace how strains are related and have evolved.
With the use of computer programmes, they also tracked how genetically related strains spread between horses and across regions, over time.
By adopting this approach, the team was also able to pinpoint likely transmission events and chains of infection.
The main findings were:
The research highlights the need for early diagnosis, isolation and laboratory-confirmed clearance, particularly through guttural pouch testing, before assuming a horse is infection-free.
It also advocates for tighter biosecurity and movement protocols, especially when transporting horses across regions.
Dr Abigail McGlennon, former PhD student in the Department of Pathobiology and Population Sciences at the RVC, and lead author of the paper, said: “Strangles is a challenging and distressing disease for horses, owners, yards and vets, and this work has highlighted just how easily it can be spread across the UK in a short period of time.
“This study shows how important enhanced surveillance utilising epidemiological and genomic data is to investigate and understand strangles transmission across the UK.
"Our data highlights the importance of greater awareness and adoption of post-outbreak screening protocols to confirm freedom from infection, rather than owners assuming recovery based on the resolution of clinical signs.”
Bayer Animal Health has organised for prominent clinical microbiologist Dr Joseph Blondeau, from Canada's University of Saskatchewana, to tour the UK in May, giving talks to practitioners about effective antibiotic usage to prevent bacterial resistance.
Bayer's Technical Veterinary Adviser, Lucy Smith, will also be giving a talk: Maximise Treatment Success, which comes at the subject from the practical veterinary side.
Bayer Animal Health Marketing Manager, Dr Markus Edingloh said: "We are incredibly fortunate to work with such an eminent expert. Dr Blondeau is a leading authority on a new parameter that supports a dosing concept to minimise selection of bacterial resistance - the Mutant Prevention Concentration. Fortunately, he is also expert at presenting complex matters in an engaging and memorable way."
He added: "Lucy Smith will share her specific experience of Bayer's recently launched Veraflox (pradofloxacin), the first and only next generation veterinary fluoroquinolone, which has a broad spectrum of treatment which attacks Gram +, Gram - and anaerobic bacteria, in a highly efficacious way.
The evening events take place on: May 14th (Glasgow), May 15th (Derby), May 16th (Swindon) & May 17th (Surrey). Full details in the VetSurgeon Diary.
Each roadshow session is equivalent to 1.5 hours of free Continuing Professional Development (CPD).
To register to attend one of the roadshows, please email animal.health@bayer.com
The RCVS has announced that voting is now open for the 2016 Council elections.
Ballot papers with candidate details, biographies and manifestos have been posted to all veterinary surgeons this week.
Eight candidates are standing in the RCVS Council election this year, with the six who receive the most votes joining Council at RCVS Day on Friday 15 July 2016 for a four-year term. The candidates are:
Each candidate in both elections has produced a short video in which they answer two questions which they have selected from those submitted to the RCVS in advance by members of the professions. The videos can be viewed at: www.rcvs.org.uk/vetvote16 along with their biographies, manifesto statements and contact details.
Bradley Viner, RCVS President, said: "Last year the candidate videos had over 3,500 views and we hope to increase that this year as it is a very direct and democratic way of finding out more about each candidate and their views. I would urge each member of the profession, whether vets or veterinary nurses, to make a vote for their preferred candidates as they really can make a difference when it comes to the future direction of the College."
All votes must be cast, either online or by post, by 5pm on Friday 29 April 2016. Online votes for RCVS Council candidates can be made at www.ersvotes.com/vetvote16.
Any veterinary surgeon who has not received a ballot paper should contact Ian Holloway, RCVS Communications Manager, on 020 7202 0727 or i.holloway@rcvs.org.uk.
The event, put together by BSAVA volunteers and sponsored by Hill’s Pet Nutrition, is designed to offer students a fun, interactive day of clinical and non-clinical content, counting towards six hours of EMS. The Association says it has been specifically tailored to support students in preparation for their careers in small animal practice.
AVS President, Isobel Arthur and AVS Junior Vice President, Calum McIntyre said: “The BSAVA Student Conference is a great opportunity for students to enhance their learning on a variety of engaging topics. Students will also be provided with the unique opportunity to talk with various expert clinicians, offering valuable insights into their fields in a time when access to seeing practice is more limited."
The day will include panel discussions, expert Q&A, quizzes and polls, plus the chance to talk to others using an online chat platform.
More content will be made available the day after the event, consisting of five webinars providing clinical guidance on; cardiology, exotics, surgery, nutraceuticals and customer care.
Alison Speakman, BSAVA Junior Vice President said: “Practice-based scenarios with student-led topics and clinical case solving of challenging issues, including fever and problematic anaesthesia patients, are aimed at facilitating a confident transition from student to graduate.
"There will also be plenty of fun, including a live BSAVA Bake-Off hosted by Rosie Brandreth-Poynter for you to showcase your cookery skills, as well as a keep fit session to help you burn some calories after you have sampled your efforts!”
This event is for BSAVA Veterinary Student members only, and costs £12. For more information and to book a place, visit: https://www.bsava.com/studentfocus
Animalcare has launched Florgane, a novel, patented, long acting florfenicol 300mg/ml suspension which the company says has significant advantages over existing organic solvent-based florfenicol products on the market when used for the treatment and prevention of bovine respiratory disease (BRD).
Florgane is an aqueous, low viscosity advanced formulation, which, claims Animalcare, means that it is easier to inject even at temperatures as low as 5°C. Low temperature syringeability is important, as a large number of calves may need to be treated during colder weather at a time when the challenge from infectious agents is greatest. A syringeability study apparently demonstrated that Florgane is up to five times faster to administer when compared to the leading florfenicol non-aqueous formulation.
A paper on the treatment of naturally occurring respiratory disease with Florgane was presented recently at the British Cattle Veterinary Association (BCVA) Congress in Torquay. According to the company, the multi-centre field studies in Belgium, Germany and Italy, in over 400 cattle with bodyweights ranging between 73-180kg, demonstrated that Florgane given by a single intramuscular injection, at a 25% lower dose of 30mg/kg, is as efficacious as non-aqueous florfenicol 40mg/kg administered by subcutaneous injection, measured by treatment success and relapses.
Post mortem examination at day 27 (meat withdrawal of 37 days) confirmed that, despite being given via the intramuscular route, Florgane is well tolerated at the site of injection due to its aqueous base and physiological pH. Maximum volume per injection site is 15ml allowing calves up to 150kg to be treated.
Animalcare adds that a further advantage of Florgane is that it persists in plasma above the MICs for the three most common pathogens for significantly longer than conventional extended action 300mg/ml florfenicol solution preparations - thereby prolonging bacterial killing time. Therefore, owing to its improved bioavailability and excellent pharmacokinetics, Florgane can be given at an easy to remember dose of 1ml per 10kg.
Tony Liepman, Marketing Manager at Animalcare said: "Using Florgane will result in faster administration, resulting in less stress for the calves and a saving in time and money for the farmer."
Florgane is presented in polypropylene 100ml and 250ml multi-dose vials with a three year shelf-life.
For more information, visit www.animalcare.co.uk
Her Royal Highness Princess Anne has opened the Royal Veterinary College's new Teaching and Research Centre.
The Centre - at the college's Hawkshead Campus in Potters Bar, Hertfordshire - will provide a home for the RVC's lifestyle research, which includes conditions such as obesity/diabetes, chronic kidney disease and arthritis as well as those with genetic roots.
RVC Principal Professor Stuart Reid said: "The RVC is extremely proud to have welcomed Her Royal Highness to open the new Teaching and Research Centre - a facility where our students are taught within an environment that is all about advanced scientific discovery and first class research. The building houses the engine of academic enquiry and is a wonderful space where our academic community generates new insights into diseases that affect humans and animals.
"The Centre allows us to tie together the various threads we have around the study of illnesses that result from lifestyle in humans and animals, such as those associated with age or genetic disorders. Our College collaborates with the research hub that is the London scientific research community. We are extremely well placed to carry out the work in conjunction with human medical research groups and bring the veterinary perspective to the understanding of disease. The building offers new opportunities, both nationally and internationally".
Funding for the building of the new centre was provided by HEFCE and The Wolfson Foundation.
Photo: Paul West
BSAVA Congress was invaded by Orangemen this year to promote the Vet Charity Challenge (VCC) taking place on 15th September 2012.
Veterinary surgeons and industry colleagues are being encouraged to take part in the one day event in which teams of four will complete a series of physical tasks and puzzle-solving challenges. Teams can choose their own routes which include walking / running, cycling and kayaking stages and can make it as easy or hard as they like.
The Vet Charity Challenge is hoping to raise in excess of £20,000 for Hounds for Heroes; SPANA, and Pet Blood Bank. VCC says it will be a great PR opportunity for practices and an opportunity for team-building.
The event will take place at the Royal Agricultural College, Cirencester and all details may be found on www.vetcharitychallenge.co.uk or by phoning 01727 859259. The VCC will provide training guidelines and sponsorship forms. Places are limited so early booking is advisable. To be sure of a place, practices and business are urged to book their team of four by the deadline of Friday 29th June 2012.
The Vet Charity Challenge is sponsored by BCF Technology, Kruuse UK Ltd and Vets2.net and is supported by the VPMA, Mojo Consultancy and JCA Media Group.